Search research articles
Contact Us
Filters
Showing results (101-110 of 131) with videos related to
Page
of 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2001
Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development
V A Papadimitrakopoulou, J Izzo, L Mao, et al.
Cancer
|
April 3, 2001
Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma
D M Shin, F R Khuri, B S Glisson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 15, 1995
Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer
R Komaki, D M Shin, B S Glisson, et al.
Allergy
|
June 3, 2016
Enhanced Th2 cell differentiation and function in the absence of Nox2
B-I Kwon, T W Kim, K Shin, et al.
Oncogene
|
February 21, 2017
Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis
L Jin, J Chun, C Pan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2001
Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer
F R Khuri, J R Rigas, R A Figlin, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
October 16, 1999
Biochemoprevention for dysplastic lesions of the upper aerodigestive tract
V A Papadimitrakopoulou, G L Clayman, D M Shin, et al.
Cancer
|
September 1, 1991
Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer
J S Lee, H I Libshitz, F V Fossella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer
F V Fossella, S M Lippman, D M Shin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 1997
Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention
D M Shin, X C Xu, S M Lippman, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 131) with videos related to
Sort By:
Page
of 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 12, 2001
Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development
V A Papadimitrakopoulou, J Izzo, L Mao, et al.
Cancer
|
April 3, 2001
Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma
D M Shin, F R Khuri, B S Glisson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 15, 1995
Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer
R Komaki, D M Shin, B S Glisson, et al.
Allergy
|
June 3, 2016
Enhanced Th2 cell differentiation and function in the absence of Nox2
B-I Kwon, T W Kim, K Shin, et al.
Oncogene
|
February 21, 2017
Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis
L Jin, J Chun, C Pan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 16, 2001
Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer
F R Khuri, J R Rigas, R A Figlin, et al.
Archives of Otolaryngology--Head & Neck Surgery
|
October 16, 1999
Biochemoprevention for dysplastic lesions of the upper aerodigestive tract
V A Papadimitrakopoulou, G L Clayman, D M Shin, et al.
Cancer
|
September 1, 1991
Edatrexate improves the antitumor effects of cyclophosphamide and cisplatin against non-small cell lung cancer
J S Lee, H I Libshitz, F V Fossella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1997
Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer
F V Fossella, S M Lippman, D M Shin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 1, 1997
Accumulation of p53 protein and retinoic acid receptor beta in retinoid chemoprevention
D M Shin, X C Xu, S M Lippman, et al.
Page
of 14